Identification of high-risk factors as indicators for adjuvant therapy in stage II colon cancer patients treated at a single institution

Por YAMAGUCHI, KEIZO, OGATA, YUTAKA, AKAGI, YOSHITO, SHIROUZU, KAZUO
Publicado em 2013

Circulating endothelial progenitor cells in metronomic chemotherapy using irinotecan and/or bevacizumab for colon carcinoma: Study of their clinical significance

Por MURAKAMI, HIDETSUGU, OGATA, YUTAKA, AKAGI, YOSHITO, ISHIBASHI, NOBUYA, SHIROUZU, KAZUO
Publicado em 2011

Demethylation effect of the antineoplaston AS2-1 on genes in colon cancer cells

Por USHIJIMA, MASATAKA, OGATA, YUTAKA, TSUDA, HIDEAKI, AKAGI, YOSHITO, MATONO, KEIKO, SHIROUZU, KAZUO
Publicado em 2014

Histocompatibility Leukocyte Antigen‐A2402‐restricted Cytotoxic T Lymphocytes Recognizing Adenocarcinoma in Tumor‐infiltrating Lymphocytes of Patients with Colon Cancer

Por Gohara, Rumi, Nakao, Masanobu, Ogata, Yutaka, Isomoto, Hiroharu, Oizumi, Kotaro, Itoh, Kyogo
Publicado no Jpn J Cancer Res (1997)

Randomized Phase II Study of 5-Fluorouracil Hepatic Arterial Infusion with or without Antineoplastons as an Adjuvant Therapy after Hepatectomy for Liver Metastases from Colorectal...

Por Ogata, Yutaka, Matono, Keiko, Tsuda, Hideaki, Ushijima, Masataka, Uchida, Shinji, Akagi, Yoshito, Shirouzu, Kazuo
Publicado no PLoS One (2015)

Preventive effects of amino-acid-rich elemental diet Elental(®) on chemotherapy-induced oral mucositis in patients with colorectal cancer: a prospective pilot study

Por Ogata, Yutaka, Ishibashi, Nobuya, Yamaguchi, Keizou, Uchida, Shinji, Kamei, Hideki, Nakayama, Goichi, Hirakawa, Hiroaki, Tanigawa, Masahiko, Akagi, Yoshito
Publicado no Support Care Cancer (2015)

Multicenter Phase II Study of a New Effective S-1 and Irinotecan Combination Schedule in Patients with Unresectable Metastatic or Recurrent Colorectal Cancer

Por Ogata, Yutaka, Tanaka, Takaho, Akagi, Yoshito, Ishibashi, Nobuya, Tsuji, Yoshiaki, Matono, Keiko, Isobe, Makoto, Sueyoshi, Susumu, Kaibara, Atsushi, Shirouzu, Kazuo
Publicado em 2013

An Observational Study of Team Management Approach for CapeOX Therapy in Patients with Advanced and Recurrent Colorectal Cancer: SMILE Study (The Study of Metastatic colorectal can...

Por Matsuoka, Hiroshi, Ogata, Yutaka, Nakamura, Michio, Shibata, Yoshihisa, Munemoto, Yoshinori, Bando, Hiroyuki, Nishijima, Koji, Okuda, Hiroyuki, Terada, Itsuro, Shiroiwa, Takeru, Kishimoto, Junji, Maeda, Kotaro
Publicado no J Anus Rectum Colon (2020)

A prospective study of XELOX plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer (KSCC 0902)

Por Ogata, Yutaka, Shimokawa, Mototsugu, Tanaka, Takaho, Emi, Yasunori, Oki, Eiji, Saeki, Hiroshi, Sadanaga, Noriaki, Kusumoto, Tetsuya, Touyama, Tetsuo, Kimura, Masami, Baba, Hideo, Akagi, Yoshito, Shirouzu, Kazuo, Maehara, Yoshihiko
Publicado no Int J Clin Oncol (2015)

JOIN trial: treatment outcome and recovery status of peripheral sensory neuropathy during a 3-year follow-up in patients receiving modified FOLFOX6 as adjuvant treatment for stage...

Por Yoshino, Takayuki, Kotaka, Masahito, Shinozaki, Katsunori, Touyama, Tetsuo, Manaka, Dai, Matsui, Takanori, Ishigure, Kiyoshi, Hasegawa, Junichi, Inoue, Keiji, Munemoto, Yoshinori, Takagane, Akinori, Ishikawa, Hiroshi, Ishida, Hideyuki, Ogata, Yutaka, Oba, Koji, Goto, Koichi, Sakamoto, Junichi, Maehara, Yoshihiko, Ohtsu, Atsushi
Publicado no Cancer Chemother Pharmacol (2019)

Changes in expression levels of ERCC1, DPYD, and VEGFA mRNA after first-line chemotherapy of metastatic colorectal cancer: results of a multicenter study

Por Baba, Hideo, Baba, Yoshifumi, Uemoto, Shinji, Yoshida, Kazuhiro, Saiura, Akio, Watanabe, Masayuki, Maehara, Yoshihiko, Oki, Eiji, Ikeda, Yasuharu, Matsuda, Hiroyuki, Yamamoto, Masakazu, Shimada, Mitsuo, Taketomi, Akinobu, Unno, Michiaki, Sugihara, Kenichi, Ogata, Yutaka, Eguchi, Susumu, Kitano, Seigo, Shirouzu, Kazuo, Saiki, Yasumitsu, Takamori, Hiroshi, Mori, Masaki, Hirata, Toshihiko, Wakabayashi, Go, Kokudo, Norihiro
Publicado no Oncotarget (2015)

Erratum: Changes in expression levels of ERCC1, DPYD, and VEGFA mRNA after first-line chemotherapy of metastatic colorectal cancer: results of a multicenter study

Por Baba, Hideo, Baba, Yoshifumi, Uemoto, Shinji, Yoshida, Kazuhiro, Saiura, Akio, Watanabe, Masayuki, Maehara, Yoshihiko, Oki, Eiji, Ikeda, Yasuharu, Matsuda, Hiroyuki, Yamamoto, Masakazu, Shimada, Mitsuo, Taketomi, Akinobu, Unno, Michiaki, Sugihara, Kenichi, Ogata, Yutaka, Eguchi, Susumu, Kitano, Seigo, Shirouzu, Kazuo, Saiki, Yasumitsu, Takamori, Hiroshi, Mori, Masaki, Hirata, Toshihiko, Wakabayashi, Go, Kokudo, Norihiro
Publicado no Oncotarget (2015)